Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 6/2007

01-06-2007 | Breast

Lymphedema Therapy Reduces the Volume of Edema and Pain in Patients with Breast Cancer

Authors: John B. Hamner, MD, Martin D. Fleming, MD

Published in: Annals of Surgical Oncology | Issue 6/2007

Login to get access

Abstract

Background

Despite recent advances in breast-conserving surgery, upper-extremity lymphedema remains a problem for patients after the treatment of breast cancer. This study examines the results of a protocol of therapy for lymphedema in breast cancer patients.

Methods

A total of 135 patients with lymphedema after breast cancer treatment were provided a protocol of complete decongestive therapy (CDT). This involved manual lymphatic drainage, compression garments, skin care, and range-of-motion exercises. Therapy was divided into an induction phase involving twice-weekly therapy for 8 weeks and maintenance therapy individualized to patient needs. Absolute volume and percentage of volume of lymphedema was compared before and after treatment. Also assessed was the degree of chronic pain and the need for pain medication.

Results

Mean initial lymphedema volume was 709 mL, and the percentage of lymphedema was 31%. The induction phase of CDT reduced this to 473 mL and 18%, respectively. Before therapy, 76 patients had chronic pain and 41 required oral pain medication. CDT reduced this to 20 and 11, respectively. The degree of pain was also assessed on a numerical scale from 0 to 10. Those patients with chronic pain initially rated their pain at an average of 6.9. After treatment, this was reduced to 1.1.

Conclusions

Lymphedema continues to be a problem for patients with breast cancer. A program of lymphedema therapy can reduce the volume of edema and reduce pain in this population.
Literature
1.
Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1998; 83(12 Suppl American):2776–81PubMedCrossRef
2.
Kissin MW, Querce della Rovere G, Easton D, Westbury D. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73:580–4PubMedCrossRef
3.
Meric F, Buchholz TA, Mirza NQ, et al. Long term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 2002; 9:543–9PubMedCrossRef
4.
Erickson VW, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst 2001; 93:96–111PubMedCrossRef
5.
Williams AF, Vadgama A, Fraks PJ, Mortimer PS. A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer–related lymphoedema. Eur J Cancer Care 2002; 11:254–61CrossRef
6.
Mozes M, Pappa MZ, Karasik A, Reshef A, Adar A. The role of infection in post mastectomy lymphedema. Surg Annu 1982; 14:73–83PubMed
7.
McWayne J, Heiney SP. Psychologic and social sequelae of secondary lymphedema: a review. Cancer 2005; 104:457–66PubMedCrossRef
8.
Casley-Smith JR. Benzo-pyrones in the treatment of lymphoedema. Int Angiol 1999; 18:31–41PubMed
9.
Rockson SG, Miller LT, Senie R, American Cancer Society Lymphedema Workshop. Workgroup III: diagnosis and management of lymphedema. Cancer 1998; 83(12 Suppl American):2882–5PubMedCrossRef
10.
Casley-Smith JR, Boris M, Weindorf F, Lasinski B. Treatment for lymphedema of the Arm—the Casley-Smith method: a noninvasive method produces continued reduction. Cancer 199815; 83(12 Suppl American):2843–60
11.
Piller NB, Morgan RG, Casley-Smith JR. A double-blind cross-over trial of O-(beta hydroxyl-ethyl)-rotutsides (bezo-pyrones) in the treatment of lymphedema of the arms and legs. Br J Plastic Surg 1998; 41:20–7CrossRef
12.
Filippetti M, Santoro E, Graziano F, Petric M, Rinaldi G. Modern therapeutic approaches to post-mastectomy brachial lymphedema. Microsurgery 1994; 15:604–10PubMedCrossRef
13.
Gloviczki P. Principles of surgical treatment of chronic lymphoedema. Int Angiol 1999; 18:42–6PubMed
14.
Huang GK, Hu RQ, Shen YL, Pan GP. Microlymphaticovenous anastamosis for lymphedema of the external genitalia in females. Surg Gynecol Obstet 1986; 162:429–32PubMed
15.
16.
Mondry TF, Riffengurgh RH, Johnstone PA. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy. Cancer J 2004; 10:42–8PubMedCrossRef
17.
Foldi M. On the pathopysiology of arm lymphedema after treatment of breast cancer. Lymphology 1995; 28:151–8PubMed
18.
Foldi E, Foldi M, Weissleder H. Conservative treatment of lymphoedema of the limbs. Angiology 1985; 36:71–80
19.
Leduc O, Leduc A, Bourgeois P, Belgrado JP. The treatment of upper limb edema. Cancer 1998; 83(12 Suppl American):2835–9PubMedCrossRef
20.
Andersen L, Hojris I, Erlandsen M, Andersen J. Treatment of breast-cancer–related lymphedema with or without manual lymphatic drainage—a randomized study. Acta Oncol 2000; 39:399–405PubMedCrossRef
21.
Hinrichs CS, Gibbs JF, Driscoll D, et al. The effectiveness of complete decongestive therapy for the treatment of lymphedema following groin dissection for melanoma. J Surg Oncol 2004; 85:187–92PubMedCrossRef
Metadata
Title
Lymphedema Therapy Reduces the Volume of Edema and Pain in Patients with Breast Cancer
Authors
John B. Hamner, MD
Martin D. Fleming, MD
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9332-1

Other articles of this Issue 6/2007

Annals of Surgical Oncology 6/2007 Go to the issue

OriginalPaper

The Pylorus: Take It or Leave It? Systematic Review and Meta-Analysis of Pylorus-Preserving versus Standard Whipple Pancreaticoduodenectomy for Pancreatic or Periampullary Cancer

OriginalPaper

Regional Lymph Node Metastases; a Singular Manifestation of the Process of Clinical Metastases in Cancer: Contemporary Animal Research and Clinical Reports Suggest Unifying Concepts

Breast Oncology

Differential Expression and Prognostic Implications of the CCN Family Members WISP-1, WISP-2, and WISP-3 in Human Breast Cancer

Melanoma

Patterns of First-Recurrence and Post-recurrence Survival in Patients with Primary Cutaneous Melanoma After Sentinel Lymph Node Biopsy

BriefCommunication

Society of Surgical Oncology Heritage Award: Honoring Edward M. Copeland III, MD, FACS

Melanomas

Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines